Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).
Term ended Jul 11, 2025 · Low confidence
20-year base term ended Dec 29, 2024
Held by Solta Medical, Inc.
Filed Nov 12, 2012 as application 13/674,546 · Granted Nov 10, 2015
Base term plus 375 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Term ended Jul 11, 2025
2004
2026
Clock starts
Dec 29, 2004
Dec 29, 2004
Term ended
Jul 11, 2025
Jul 11, 2025
Granted
Nov 10, 2015
Nov 10, 2015
base term
patent term adjustment
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
375
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,343,051.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 375 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 29, 2004, when the earliest non-provisional application in its chain was filed (this one was filed Nov 12, 2012); a parent in its chain could not be resolved (the next row) | Dec 29, 2024 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +375 days, USPTO patent term adjustment record | Jan 8, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,343,051) | capped to Jul 11, 2025 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Further caveats on record | The record names parents not resolved: 11026519, 11026519, 11026519 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Jul 11, 2025 | Low confidence |
This family
| Application 10/751,344 | Abandoned not computed | not computed |
| Application 10/750,370 | Abandoned not computed | not computed |
| US 7,993,289 | Lapsed on the fee record Aug 2019 | Aug 2019 |
| US 8,337,407 | Lapsed on the fee record Dec 2016 | Dec 2016 |
| US 7,857,773 | In force Dec 2027 | Dec 2027 |
| US 8,343,051 | Term ended Jul 2025 | Jul 2025 |
| Application 12/954,506 | Abandoned not computed | not computed |
| US 9,180,314 | this patent Jul 2025 | Jul 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 30, 2013 Reel 31130, frame 566 | Liposonix, Inc. | Silicon Valley Bank | Security Agreement |
| Nov 19, 2013 Reel 31674, frame 454 | Liposonix, Inc. | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Liposonix, Inc. | Capital Royalty Partners II L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Liposonix, Inc. | Capital Royalty Partners II - Parallel Fund "a" L.P. | Short-Form Patent Security Agreement |
| Nov 19, 2013 reel/frame not recorded | Liposonix, Inc. | Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Jan 24, 2014 Reel 32126, frame 370 | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Liposonix, Inc. | Release of Security Interest in Patents |
| Jan 24, 2014 Reel 32126, frame 531 | Silicon Valley Bank | Liposonix, Inc. | Release of Security Interest in Patents |
| Mar 11, 2019 Reel 48556, frame 758 | Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Interest |
| May 13, 2021 Reel 56227, frame 174 | Aesthera; Liposonix, Inc. | Solta Medical, Inc. | Merger |
| Jun 8, 2021 Reel 56811, frame 814 | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Interest |
| Feb 10, 2022 Reel 59121, frame 1 | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | The Bank of New York Mellon | Security Agreement |
| Jun 13, 2022 Reel 60346, frame 705 | Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland Limited | The Bank of New York Mellon | Security Interest |
| Oct 4, 2022 Reel 61595, frame 66 | Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Agreement (First Lien) |
| Oct 5, 2022 Reel 61606, frame 468 | Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc. | The Bank of New York Mellon, as Notes Collateral Agent | Security Agreement (Second Lien) |
| Jun 13, 2025 Reel 71564, frame 463 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | The Bank of New York Mellon | U.S. Patent Security Agreement |
| Jun 13, 2025 Reel 71566, frame 200 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | Jpmorgan Chase Bank, N.a. | U.S. Patent Security Agreement |
| Nov 20, 2025 Reel 73654, frame 242 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc. | Release of Security Interest |
| Nov 20, 2025 Reel 73654, frame 300 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch & Lomb Incorporated | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Precision Dermatology, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health, Canada Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 375 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,343,051.
Citations
43
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.